ELIZABETH GOETZ: Open Payments
NPI 1649033952 · CASSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 33 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $331 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Novo Nordisk Inc | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| ABBVIE INC. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Viatris Specialty LLC | 2 | $32 |
| Lundbeck LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: CAPLYTA, REXULTI, BREZTRI, Ozempic, UBRELVY, Wegovy, JARDIANCE, YUPELRI.
Industry payments across MO — which companies pay providers there.
